Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tregs in Autoimmune Hepatitis
NCT02704338Phase 2Unknown
- Sponsor
- Nanjing Medical University
- Start
- Apr 2016
- Primary completion
- Mar 2018
- Modality
- Cell Therapies
01
Overview
A Phase 2 trial of autologous regulatory T cells in autoimmune hepatitis (AIH), sponsored by Nanjing Medical University. Status: unknown.
02
Drugs
autologous regulatory T cells
03
Conditions
autoimmune hepatitis (AIH)
Beyond the preview
Go deeper on NCT02704338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02704338.